{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:31:11Z","timestamp":1786980671797,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s10384-024-01064-4","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T02:02:25Z","timestamp":1723773745000},"page":"367-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Congenital nasolacrimal duct obstruction: clinical guideline"],"prefix":"10.1007","volume":"68","author":[{"given":"Tsugihisa","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kamao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomichi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Shinomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Congenital Nasolacrimal Duct Obstruction: Clinical Guideline Preparation Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee for Congenital Nasolacrimal Duct Obstruction Clinical Guideline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"1064_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/bmj.315.7103.293","volume":"315","author":"JD Young","year":"1997","unstructured":"Young JD, MacEwen CJ. Managing congenital lacrimal obstruction in general practice. BMJ. 1997;315:293\u20136.","journal-title":"BMJ"},{"key":"1064_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/eye.1991.103","volume":"5","author":"CJ MacEwen","year":"1991","unstructured":"MacEwen CJ, Young JD. Epiphora during the first year of life. Eye (Lond). 1991;5:596\u2013600.","journal-title":"Eye (Lond)"},{"key":"1064_CR3","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1001\/archophthalmol.2012.2853","volume":"130","author":"Pediatric Eye Disease Investigator Group","year":"2012","unstructured":"Pediatric Eye Disease Investigator Group. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction. Arch Ophthalmol. 2012;130:1525\u201333.","journal-title":"Arch Ophthalmol"},{"key":"1064_CR4","first-page":"CD011109","volume":"12","author":"C Petris","year":"2017","unstructured":"Petris C, Liu D. Probing for congenital nasolacrimal duct obstruction. Cochrane Database Syst Rev. 2017;12:CD011109.","journal-title":"Cochrane Database Syst Rev"},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s10384-016-0445-1","volume":"60","author":"M Fujimoto","year":"2016","unstructured":"Fujimoto M, Ogino K, Matsuyama H, Miyazaki C. Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction. Jpn J Ophthalmol. 2016;60:274\u20139.","journal-title":"Jpn J Ophthalmol"},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41433-019-0374-6","volume":"33","author":"N Matsumura","year":"2019","unstructured":"Matsumura N, Suzuki T, Goto S, Fujita T, Yamane S, Maruyama-Inoue M, et al. Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction. Eye (Lond). 2019;33:1008\u201313.","journal-title":"Eye (Lond)"},{"key":"1064_CR7","unstructured":"Minds Manual Developing Committee: Minds Manual for Guideline Development 2020 ver. 3.0. https:\/\/minds.jcqhc.or.jp\/s\/manual_2020_3_0. Accessed 12 Sept 2022."},{"key":"1064_CR8","unstructured":"The AGREE Next Steps Consortiumt: The AGREE II. http:\/\/www.agreetrust.org. Accessed 12 Sept 2022."},{"key":"1064_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jama.1923.02650010027009","volume":"81","author":"LW Crigler","year":"1923","unstructured":"Crigler LW. The treatment of congenital dacryocystitis. JAMA. 1923;81:23\u20134.","journal-title":"JAMA"},{"key":"1064_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archopht.1982.01030030599010","volume":"100","author":"BJ Kushner","year":"1982","unstructured":"Kushner BJ. Congenital nasolacrimal system obstruction. Arch Ophthalmol. 1982;100:597\u2013600.","journal-title":"Arch Ophthalmol"},{"key":"1064_CR11","first-page":"337","volume":"31","author":"D Shivpuri","year":"1994","unstructured":"Shivpuri D, Puri A. Congenital nasolacrimal duct obstruction: the proper technique of massage. Indian Pediatr. 1994;31:337\u201340.","journal-title":"Indian Pediatr"},{"key":"1064_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10792-016-0208-5","volume":"36","author":"O Karti","year":"2016","unstructured":"Karti O, Karahan E, Acan D, Kusbeci T. The natural process of CT and effect of lacrimal sac massage. Int Ophthalmol. 2016;36:845\u20139.","journal-title":"Int Ophthalmol"},{"key":"1064_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0161-6420(85)33878-2","volume":"92","author":"LR Nelson","year":"1985","unstructured":"Nelson LR, Calhoun JH, Menduke H. Medical management of congenital nasolacrimal duct obstruction. Ophthalmology. 1985;92:87\u201390.","journal-title":"Ophthalmology"},{"key":"1064_CR14","first-page":"20","volume":"28","author":"S Noda","year":"1991","unstructured":"Noda S, Hayasaka S, Setogawa T. Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with massage. J Pediatr Ophthalmol Strabismus. 1991;28:20\u20132.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3928\/0191-3913-19890101-10","volume":"26","author":"P Nucci","year":"1989","unstructured":"Nucci P, Capoferri C, Alfarano R, Brancato R. Conservative management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 1989;26:39\u201343.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3928\/0191-3913-19850301-09","volume":"22","author":"TO Paul","year":"1985","unstructured":"Paul TO. Medical management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 1985;22:68\u201370.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR17","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1136\/bjophthalmol-2021-318853","volume":"106","author":"BG Mohney","year":"2022","unstructured":"Mohney BG, Sathiamoorthi S, Frank RD. Spontaneous resolution rates in congenital nasolacrimal duct obstruction managed with massage or topical antibiotics compared with observation alone. Br J Ophthalmol. 2022;106:1196\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1064_CR18","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41433-020-01125-1","volume":"35","author":"O Bansal","year":"2021","unstructured":"Bansal O, Bothra N, Sharma A, Walvekar P, Ali MJ. Congenital nasolacrimal duct obstruction update study (CUP study): paper I-role and outcomes of Crigler\u2019s lacrimal sac compression. Eye (Lond). 2021;35:1600\u20134.","journal-title":"Eye (Lond)"},{"key":"1064_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3109\/02713683.2014.898312","volume":"39","author":"V Prokosch","year":"2014","unstructured":"Prokosch V, Prokosch JE, Promesberger J, Idelevich EA, B\u00f6hm MR, Thanos S, et al. Bacterial spectrum and antimicrobial susceptibility patterns in acquired and connatal lacrimal duct stenosis. Curr Eye Res. 2014;39:1069\u201375.","journal-title":"Curr Eye Res"},{"key":"1064_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jaapos.2006.04.009","volume":"10","author":"K Usha","year":"2006","unstructured":"Usha K, Smitha S, Shah N, Lalitha P, Kelkar R. Spectrum and the susceptibilities of microbial isolates in cases of congenital nasolacrimal duct obstruction. J AAPOS. 2006;10:469\u201372.","journal-title":"J AAPOS"},{"key":"1064_CR21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1034\/j.1600-0420.2000.078006694.x","volume":"78","author":"A Kuchar","year":"2000","unstructured":"Kuchar A, Lukas J, Steinkogler FJ. Bacteriology and antibiotic therapy in congenital nasolacrimal duct obstruction. Acta Ophthalmol Scand. 2000;78:694\u20138.","journal-title":"Acta Ophthalmol Scand"},{"key":"1064_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcrs.2016.10.024","volume":"43","author":"R Nejima","year":"2017","unstructured":"Nejima R, Shimizu K, Ono T, Noguchi Y, Yagi A, Iwasaki T, et al. Effect of the administration period of perioperative topical levofloxacin on normal conjunctival bacterial flora. J Cataract Refract Surg. 2017;43:42\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"1064_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/archophthalmol.2012.454","volume":"130","author":"Pediatric Eye Disease Investigator Group","year":"2012","unstructured":"Pediatric Eye Disease Investigator Group. Resolution of congenital nasolacrimal duct obstruction with nonsurgical management. Arch Ophthalmol. 2012;130:730\u20134.","journal-title":"Arch Ophthalmol"},{"key":"1064_CR24","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamaophthalmol.2018.3841","volume":"136","author":"S Sathiamoorthi","year":"2018","unstructured":"Sathiamoorthi S, Frank RD, Mohney BG. Spontaneous resolution and timing of intervention in congenital nasolacrimal duct obstruction. JAMA Ophthalmol. 2018;136:1281\u20136.","journal-title":"JAMA Ophthalmol."},{"key":"1064_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/eye.1996.107","volume":"10","author":"JD Young","year":"1996","unstructured":"Young JD, MacEwen CJ, Ogston SA. Congenital nasolacrimal duct obstruction in the second year of life: a multicentre trial of management. Eye (Lond). 1996;10:485\u201391.","journal-title":"Eye (Lond)"},{"key":"1064_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ajo.2013.06.014","volume":"156","author":"KA Lee","year":"2013","unstructured":"Lee KA, Chandler DL, Repka MX, Melia M, Beck RW, Summers CG, et al. PEDIG: A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction. Am J Ophthalmol. 2013;156:1045\u201350.","journal-title":"Am J Ophthalmol"},{"key":"1064_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaapos.2013.10.016","volume":"18","author":"AM Miller","year":"2014","unstructured":"Miller AM, Chandler DL, Repka MX, Hoover DL, Lee KA, Melia M, et al. Pediatric Eye Disease Investigator Group: office probing for treatment of nasolacrimal duct obstruction in infants. J AAPOS. 2014;18:26\u201330.","journal-title":"J AAPOS"},{"key":"1064_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.pedneo.2015.04.001","volume":"56","author":"CH Hung","year":"2015","unstructured":"Hung CH, Chen YC, Lin SL, Chen WL. Nasolacrimal duct probing under topical anesthesia for congenital nasolacrimal duct obstruction in Taiwan. Pediatr Neonatol. 2015;56:402\u20137.","journal-title":"Pediatr Neonatol"},{"key":"1064_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1067\/mpa.2002.129041","volume":"6","author":"MB Kashkouli","year":"2002","unstructured":"Kashkouli MB, Kassaee A, Tabatabaee Z. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success. J AAPOS. 2002;6:360\u20133.","journal-title":"J AAPOS"},{"key":"1064_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3928\/0191-3913-19960701-09","volume":"33","author":"TA Goldblum","year":"1996","unstructured":"Goldblum TA, Summers CG, Egbert JE, Letson RD. Office probing for congenital nasolacrimal duct obstruction: a study of parental satisfaction. J Pediatr Ophthalmol Strabismus. 1996;33:244\u20137.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0161-6420(87)33392-5","volume":"94","author":"JA Katowitz","year":"1987","unstructured":"Katowitz JA, Welsh MG. Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology. 1987;94:698\u2013705.","journal-title":"Ophthalmology"},{"key":"1064_CR32","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/bjophthalmol-2019-314980","volume":"104","author":"T Nakayama","year":"2020","unstructured":"Nakayama T, Watanabe A, Rajak S, Yamanaka Y, Sotozono C. Congenital nasolacrimal duct obstruction continues trend for spontaneous resolution beyond first year of life. Br J Ophthalmol. 2020;104:1161\u20133.","journal-title":"Br J Ophthalmol"},{"key":"1064_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/ceo.12108","volume":"41","author":"H Sasaki","year":"2013","unstructured":"Sasaki H, Takano T, Murakami A. Direct endoscopic probing for congenital lacrimal duct obstruction. Clin Exp Ophthalmol. 2013;41:729\u201334.","journal-title":"Clin Exp Ophthalmol"},{"key":"1064_CR34","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/OPTH.S60377","volume":"8","author":"K Kato","year":"2014","unstructured":"Kato K, Matsunaga K, Takashima Y, Kondo M. Probing of congenital nasolacrimal duct obstruction with dacryoendoscope. Clin Ophthalmol. 2014;8:977\u201380.","journal-title":"Clin Ophthalmol"},{"key":"1064_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/01676830.2019.1668434","volume":"39","author":"N Gupta","year":"2020","unstructured":"Gupta N, Singla P, Kumar S, Ganesh S, Dhawan N, Sobti P, et al. Role of dacryoendoscopy in refractory cases of congenital nasolacrimal duct obstruction. Orbit. 2020;39:183\u20139.","journal-title":"Orbit"},{"key":"1064_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12886-021-01948-w","volume":"21","author":"Y Li","year":"2021","unstructured":"Li Y, Wei M, Liu X, Zhang L, Song X, Xiao C. Dacryoendoscopy-assisted incision of Hasner\u2019s valve under nasoendoscopy for membranous congenital nasolacrimal duct obstruction after probing failure: a retrospective study. BMC Ophthalmol. 2021;21:182.","journal-title":"BMC Ophthalmol"},{"key":"1064_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211008047","author":"N Gupta","year":"2021","unstructured":"Gupta N, Singla P, Ganesh S. Usefulness of high definition sialoendoscope for evaluation of lacrimal drainage system in congenital nasolacrimal duct obstruction. Eur J Ophthalmol. 2021. https:\/\/doi.org\/10.1177\/11206721211008047","journal-title":"Eur J Ophthalmol"},{"key":"1064_CR38","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s12325-017-0517-8","volume":"34","author":"J Heichel","year":"2017","unstructured":"Heichel J, Struck HG, Fiorentzis M, Hammer T, Bredehorn-Mayr T. A case series of dacryoendoscopy in childhood: a diagnostic and therapeutic alternative for complex congenital nasolacrimal duct obstruction even in the first year of life. Adv Ther. 2017;34:1221\u201332.","journal-title":"Adv Ther"},{"key":"1064_CR39","first-page":"91","volume":"118","author":"K Hayashi","year":"2014","unstructured":"Hayashi K, Katori N, Komatsu H, Ono K. Spontaneous resolving rate of congenital nasolacrimal duct obstruction and success rate of late probing after age 18 months: Historical cohort study. Nippon Ganka Gakkai Zasshi. 2014;118:91\u20137 (in Japanese).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"1064_CR40","first-page":"505","volume":"70","author":"K Watanabe","year":"2016","unstructured":"Watanabe K, Watanabe K. Endoscopic findings of congenital nasolacrimal duct obstruction in infants. Rinsho Ganka. 2016;70:505\u20138 ((in Japanese)).","journal-title":"Rinsho Ganka"},{"key":"1064_CR41","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1001\/archophthalmol.2012.2853","volume":"130","author":"Pediatric Eye Disease Investigator Group","year":"2012","unstructured":"Pediatric Eye Disease Investigator Group. Arandomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction. Arch Ophthalmol. 2012;130:1525\u201333.","journal-title":"Arch Ophthalmol"},{"key":"1064_CR42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jaapos.2009.02.008","volume":"13","author":"MX Repka","year":"2009","unstructured":"Repka MX, Chandler DL, Bremer DL, Collins ML, Lee DH, Pediatric Eye Disease Investigator Group. Repeat probing for treatment of persistent nasolacrimal duct obstruction. J AAPOS. 2009;13:306\u20137.","journal-title":"J AAPOS"},{"key":"1064_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0002-9394(00)00388-3","volume":"130","author":"SG Honavar","year":"2000","unstructured":"Honavar SG, Prakash VE, Rao GN. Outcome of probing for congenital nasolacrimal duct obstruction in older children. Am J Ophthalmol. 2000;130:42\u20138.","journal-title":"Am J Ophthalmol"},{"key":"1064_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3341\/kjo.2010.24.5.261","volume":"24","author":"DS Cha","year":"2010","unstructured":"Cha DS, Lee H, Park MS, Lee JM, Baek SH. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction. Korean J Ophthalmol. 2010;24:261\u20136.","journal-title":"Korean J Ophthalmol"},{"key":"1064_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2478\/folmed-2018-0054","volume":"61","author":"KP Valcheva","year":"2019","unstructured":"Valcheva KP, Murgova SV, Krivoshiiska EK. Success rate of probing for congenital nasolacrimal duct obstruction in children. Folia Med (Plovdiv). 2019;61:97\u2013103.","journal-title":"Folia Med (Plovdiv)."},{"key":"1064_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3928\/01913913-20161013-02","volume":"54","author":"J Beato","year":"2017","unstructured":"Beato J, Mota \u00c1, Gon\u00e7alves N, Santos-Silva R, Maga lh\u00e3es A, Breda J, et al. Factors predictive of success in probing for congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 2017;54:123\u20137.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3928\/01913913-20160629-01","volume":"53","author":"ML Napier","year":"2016","unstructured":"Napier ML, Armstrong DJ, McLoone SF, McLoone EM. Congenital nasolacrimal duct obstruction: comparison of two different treatment algorithms. J Pediatr Ophthalmol Strabismus. 2016;53:285\u201391.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR48","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4103\/ijo.IJO_1819_18","volume":"67","author":"M Singh","year":"2019","unstructured":"Singh M, Sharma M, Kaur M, Grewal AM, Yadav D, Handa S, et al. Nasal endoscopic features and outcomes of nasal endoscopy guided bicanalicular intubation for complex persistent congenital nasolacrimal duct obstructions. Indian J Ophthalmol. 2019;67:1137\u201342.","journal-title":"Indian J Ophthalmol"},{"key":"1064_CR49","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0165-5876(97)00088-8","volume":"41","author":"M Orhan","year":"1997","unstructured":"Orhan M, Onerci M. Intranasal endoscopic silicone intubation for congenital obstruction of the nasolacrimal duct in children. Int J Pediatr Otorhinolaryngol. 1997;41:273\u20138.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1064_CR50","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bjo.2005.069286","volume":"89","author":"JE Marr","year":"2005","unstructured":"Marr JE, Drake-Lee A, Willshaw HE. Management of childhood epiphora. Br J Ophthalmol. 2005;89:1123\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1064_CR51","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/112067210001000409","volume":"10","author":"F Cift\u00e7i","year":"2000","unstructured":"Cift\u00e7i F, Akman A, S\u00f6nmez M, Unal M, G\u00fcng\u00f6r A, Yaylali V. Systematic, combined treatment approach to nasolacrimal duct obstruction in different age groups. Eur J Ophthalmol. 2000;10:324\u20139.","journal-title":"Eur J Ophthalmol"},{"key":"1064_CR52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.iop.0000225750.25592.7f","volume":"22","author":"DR Casady","year":"2006","unstructured":"Casady DR, Meyer DR, Simon JW, Stasior GO, Zobal-Ratner JL. Stepwise treatment paradigm for congenital nasolacrimal duct obstruction. Ophthalmic Plast Reconstr Surg. 2006;22:243\u20137.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1064_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/archophthalmol.2009.66","volume":"127","author":"MX Repka","year":"2009","unstructured":"Repka MX, Chandler DL, Holmes JM, Hoover DL, Morse CL, Schloff S, et al. Pediatric Eye Disease Investigator Group: balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing. Arch Ophthalmol. 2009;127:633\u20139.","journal-title":"Arch Ophthalmol"},{"key":"1064_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/01.IOP.0000134271.25794.96","volume":"20","author":"SM Goldstein","year":"2004","unstructured":"Goldstein SM, Goldstein JB, Katowitz JA. Comparison of monocanalicular stenting and balloon dacryoplasty in secondary treatment of congenital nasolacrimal duct obstruction after failed primary probing. Ophthalmic Plast Reconstr Surg. 2004;20:352\u20137.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1064_CR55","first-page":"49","volume":"66","author":"B Eshraghi","year":"2022","unstructured":"Eshraghi B, Ghadimi H, Karami S, Nikdel M. Outcome of monocanalicular intubation for complex congenital nasolacrimal duct obstruction: the role of age. Rom J Ophthalmol. 2022;66:49\u201354.","journal-title":"Rom J Ophthalmol."},{"key":"1064_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaapos.2012.09.012","volume":"17","author":"SP Donahue","year":"2013","unstructured":"Donahue SP, Arthur B, Neely DE, Arnold RW, Silbert D, Ruben JB, POS Vision Screening Committee. Guidelines for automated preschool vision screening: a 10-year, evidence-based update. J AAPOS. 2013;17:4\u20138.","journal-title":"J AAPOS"},{"key":"1064_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaapos.2011.05.007","volume":"15","author":"NS Matta","year":"2011","unstructured":"Matta NS, Silbert DI. High prevalence of amblyopia risk factors in preverbal children with nasolacrimal duct obstruction. J AAPOS. 2011;15:350\u20132.","journal-title":"J AAPOS"},{"key":"1064_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217802","volume":"14","author":"Y Yoo","year":"2019","unstructured":"Yoo Y, Yang HK, Kim N, Choung HK, Hwang JM, Khwarg SI. Amblyopia risk factors in congenital nasolacrimal duct obstruction: a longitudinal case-control study. PLoS ONE. 2019;14: e0217802.","journal-title":"PLoS ONE"},{"key":"1064_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3928\/01913913-20191111-01","volume":"57","author":"A Vagge","year":"2020","unstructured":"Vagge A, Tulumello C, Pellegrini M, Di Maita M, Iester M, Traverso CE. Amblyopia risk factors in newborns with congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 2020;57:39\u201343.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR60","first-page":"787","volume":"73","author":"A Kondo","year":"2019","unstructured":"Kondo A, Matsumura N, Asano M, Fujita, Mizuki N. Refractometry for screening of amblyopia in infants with unilateral congenital nasolacrimal duct by SpotTM vision screener. Rinsho Ganka. 2019;73:787\u201391.","journal-title":"Rinsho Ganka"},{"key":"1064_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/uog.20857","volume":"55","author":"A Ficara","year":"2020","unstructured":"Ficara A, Syngelaki A, Hammami A, Akolekar R, Nicolaides KH. Value of routine ultrasound examination at 35\u201337 weeks\u2019 gestation in diagnosis of fetal abnormalities. Ultrasound Obstet Gynecol. 2020;55:75\u201380.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1064_CR62","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00330-010-1755-1","volume":"20","author":"PC Brugger","year":"2010","unstructured":"Brugger PC, Weber M, Prayer D. Magnetic resonance imaging of the fetal efferent lacrimal pathways. Eur Radiol. 2010;20:1965\u201373.","journal-title":"Eur Radiol"},{"key":"1064_CR63","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1007\/s00247-010-1719-2","volume":"40","author":"Z Yazici","year":"2010","unstructured":"Yazici Z, Kline-Fath BM, Yazici B, Rubio EI, Calvo-Garcia MA, Linam LE. Congenital dacryocystocele: prenatal MRI findings. Pediatr Radiol. 2010;40:1868\u201373.","journal-title":"Pediatr Radiol"},{"key":"1064_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14366\/usg.14037","volume":"34","author":"YH Kim","year":"2015","unstructured":"Kim YH, Lee YJ, Song MJ, Han BH, Lee YH, Lee KS. Dacryocystocele on prenatal ultrasonography: diagnosis and postnatal outcomes. Ultrasonography. 2015;34:51\u20137.","journal-title":"Ultrasonography"},{"key":"1064_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/pd.4494","volume":"35","author":"SL Li","year":"2015","unstructured":"Li SL, Luo GY, Tian XX, Yu R, Norwitz ER, Qin FZ, et al. Prenatal diagnosis and perinatal outcome of congenital dacryocystocele: a large case series. Prenat Diagn. 2015;35:103\u20137.","journal-title":"Prenat Diagn"},{"key":"1064_CR66","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/eye.2017.235","volume":"32","author":"R Davies","year":"2018","unstructured":"Davies R, Watkins WJ, Kotecha S, Watts P. The presentation, clinical features, complications, and treatment of congenital dacryocystocele. Eye (Lond). 2018;32:522\u20136.","journal-title":"Eye (Lond)"},{"key":"1064_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jaapos.2010.07.006","volume":"14","author":"J Shekunov","year":"2010","unstructured":"Shekunov J, Griepentrog GJ, Diehl NN, Mohney BG. Prevalence and clinical characteristics of congenital dacryocystocele. J AAPOS. 2010;14:417\u201320.","journal-title":"J AAPOS"},{"key":"1064_CR68","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jcjo.2018.08.006","volume":"54","author":"MJ Lee","year":"2019","unstructured":"Lee MJ, Park J, Kim N, Choung HK, Khwarg SI. Conservative management of congenital dacryocystocele: resolution and complications. Can J Ophthalmol. 2019;54:421\u20135.","journal-title":"Can J Ophthalmol"},{"key":"1064_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1120672118785276","volume":"29","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Fan Y, Fan J, Cui Y. Selection of surgical intervention for congenital dacryocystocele. Eur J Ophthalmol. 2019;29:158\u201364.","journal-title":"Eur J Ophthalmol"},{"key":"1064_CR70","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5301\/ejo.5000548","volume":"25","author":"L Chen","year":"2015","unstructured":"Chen L, Fang J. Proximal drainage plus massage of lacrimal sac improves the symptoms of congenital dacryocystoceles. Eur J Ophthalmol. 2015;25:293\u20137.","journal-title":"Eur J Ophthalmol"},{"key":"1064_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaapos.2012.01.004","volume":"16","author":"LR Dagi","year":"2012","unstructured":"Dagi LR, Bhargava A, Melvin P, Prabhn SP. Associated signs, demographic characteristics, and management of dacryocystocele in 64 infants. J AAPOS. 2012;16:255\u201360.","journal-title":"J AAPOS"},{"key":"1064_CR72","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1542\/peds.2008-0934","volume":"122","author":"RK Wong","year":"2008","unstructured":"Wong RK, VanderVeen DK. Presentation and management of congenital dacryocystocele. Pediatrics. 2008;122:e1108\u201312.","journal-title":"Pediatrics"},{"key":"1064_CR73","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ajo.2006.05.043","volume":"142","author":"BB Becker","year":"2006","unstructured":"Becker BB. The treatment of congenital dacryocystocele. Am J Ophthalmol. 2006;142:835\u20138.","journal-title":"Am J Ophthalmol"},{"key":"1064_CR74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S1091-8531(00)90011-9","volume":"4","author":"EA Paysse","year":"2000","unstructured":"Paysse EA, Coats DK, Bernstein JM, Go C, de Jong AL. Management and complications of congenital dacryocele with concurrent intranasal mucocele. J AAPOS. 2000;4:46\u201353.","journal-title":"J AAPOS"},{"key":"1064_CR75","first-page":"74","volume":"110","author":"GT Lueder","year":"2012","unstructured":"Lueder GT. The association of neonatal dacryocystoceles and infantile dacryocystitis with nasolacrimal duct cysts (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2012;110:74\u201393.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1064_CR76","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/S0161-6420(91)32063-3","volume":"98","author":"AM Mansour","year":"1991","unstructured":"Mansour AM, Cheng KP, Mumma JV, Stager DR, Harris GJ, Patrinely JR, et al. Congenital dacryocele. a collaborative review. Ophthalmology. 1991;98:1744\u201351.","journal-title":"Ophthalmology"},{"key":"1064_CR77","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/ped.12516","volume":"57","author":"T Kuboi","year":"2015","unstructured":"Kuboi T, Okazaki K, Kusaka T, Shimada A. Congenital dacryocystoceles controlled by nCPAP via nasal mask in a neonate. Pediatr Int. 2015;57:475\u20137.","journal-title":"Pediatr Int"},{"key":"1064_CR78","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001548","volume":"36","author":"C Ocran","year":"2020","unstructured":"Ocran C, Farivari NM, Sobel RK, Padovani-Claudio DA. Nasal trumpet protects the airway in case of bilateral dacryocystoceles. Ophthalmic Plast Reconstr Surg. 2020;36: e138.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"1064_CR79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3928\/0191-3913-19960901-04","volume":"33","author":"BM Schnall","year":"1996","unstructured":"Schnall BM, Christian CJ. Conservative treatment of congenital dacryocele. J Pediatr Ophthalmol Strabismus. 1996;33:219\u201321.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1064_CR80","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.amjoto.2009.11.009","volume":"32","author":"M Hain","year":"2011","unstructured":"Hain M, Bawnik Y, Warman M, Halperin D, Leiba H. Neonatal dacryocele with endonasal cyst: revisiting the management. Am J Otolaryngol. 2011;32:152\u20135.","journal-title":"Am J Otolaryngol"},{"key":"1064_CR81","first-page":"NC01","volume":"11","author":"BC Saha","year":"2017","unstructured":"Saha BC, Kumari R, Sinha BP. Clinical outcome of probing in infants with acute dacryocystitis-a prospective study. J Clin Diagn Res. 2017;11:NC01\u20133.","journal-title":"J Clin Diagn Res"},{"key":"1064_CR82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijporl.2019.04.043","volume":"123","author":"NW Zhao","year":"2019","unstructured":"Zhao NW, Chan DK. Awake bedside nasal endoscopy for primary management of neonatal dacryocystoceles with intranasal cysts. Int J Pediatr Otorhinolaryngol. 2019;123:93\u20136.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1064_CR83","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/archotol.1995.01890120079016","volume":"121","author":"KM Hepler","year":"1995","unstructured":"Hepler KM, Woodson GE, Kearns DB. Respiratory distress in the neonate. Sequela of a congenital dacryocystocele. Arch Otolaryngol Head Neck Surg. 1995;121:1423\u20135.","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01064-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T12:12:53Z","timestamp":1724760773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01064-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01064-4","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. Sasaki, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Senju, Alcon, Santen, Kaneka Medix, Novartis, HOYA, Nitto Medic), FiberTech and the author own the patent for medical endoscope ; N. Matsumura, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (FiberTech, Machida Endoscope, Senju, Santen); C. Miyazaki, None; T. Kamao, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Senju, Fiber Tech, Machida Endoscope, Logic & Design, Taiho, Rohto Nitten, Johnson & Johnson, Nipro); N. Yokoi, None; M. Fujimoto, None; M. Hayami, None; A. Iwasaki, None; M. Mimura, None; A. Murata, None; T. Nakayama, None; K. Shinomiya, None; H. Tanaka, None; Y. Ueta, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}